Evidence map›Paper›PMID 39370781›Full record

ArticleVirulence2024

Alkaloids solenopsins from fire ants display

Leandro Honorato, Jhon Jhamilton Artunduaga Bonilla, Larissa Ribeiro da Silva, Julio Kornetz, Daniel Zamith-Miranda, Alessandro F Valdez, Joshua D Nosanchuk, Eduardo Gonçalves Paterson Fox, Leonardo Nimrichter

Abstract read
In one paragraph

Article in Virulence, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Studies on Secondary Metabolites ofPolish journal of microbiology · 2025
    Article
  3. Article
  4. Review
  5. Journal of fungi (Basel, Switzerland) · 2025
    Review
  6. Innovative antifungal strategies to combat drug-resistantFrontiers in cellular and infection microbiology · 2025
    Review
  7. Therapeutic Potential ofBiomolecules · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Leandro HonoratoUniversidade Federal do Rio de Janeiro, Instituto de Microbiologia Paulo de Góes, Departamento de Microbiologia Geral, Rio de Janeiro, Brazil.
Jhon Jhamilton Artunduaga BonillaUniversidade Federal do Rio de Janeiro, Instituto de Microbiologia Paulo de Góes, Departamento de Microbiologia Geral, Rio de Janeiro, Brazil.
Larissa Ribeiro da SilvaUniversidade Federal do Rio de Janeiro, Instituto de Microbiologia Paulo de Góes, Departamento de Microbiologia Geral, Rio de Janeiro, Brazil.
Julio KornetzUniversidade Federal do Rio de Janeiro, Instituto de Microbiologia Paulo de Góes, Departamento de Microbiologia Geral, Rio de Janeiro, Brazil.
Daniel Zamith-MirandaDepartments of Medicine (Division of Infectious Diseases) and Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Alessandro F ValdezUniversidade Federal do Rio de Janeiro, Instituto de Microbiologia Paulo de Góes, Departamento de Microbiologia Geral, Rio de Janeiro, Brazil.
Joshua D NosanchukDepartments of Medicine (Division of Infectious Diseases) and Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Eduardo Gonçalves Paterson FoxPrograma de Pós-Graduação em Ambiente e Sociedade (PPGAS), Universidade Estadual de Goiás (UEG), Quirinópolis, Brazil.
Leonardo NimrichterUniversidade Federal do Rio de Janeiro, Instituto de Microbiologia Paulo de Góes, Departamento de Microbiologia Geral, Rio de Janeiro, Brazil.ORCID 0000-0001-9281-6856

Funding

The biology of Cryptococcus neoformans melanizationR01AI171093 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Arturo Casadevall, JOSHUA D NOSANCHUK · 2023 to 2026
$3.2M
Antibody differentially alters Histoplasma extracellular vesiclesR21AI124797 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI NOSANCHUK, JOSHUA D · 2016 to 2017
$538k
Candida auris extracellular vesicles subvert host immune responsesR21AI156104 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI NOSANCHUK, JOSHUA D · 2021 to 2022
$462k
An extracellular vesicle component as a candidate to control cryptococcosis.R01AI183314 · NIAID · FUNDACAO OSWALDO CRUZ · PI JOSHUA D NOSANCHUK, Marcio Lourenco Rodrigues · 2024 to 2026
$380k
NIAID NIH HHS R01 AI171093NIAID NIH HHS R01 AI183314NIAID NIH HHS R21 AI124797NIAID NIH HHS R21 AI156104
6 · The paper itself

Abstract

The urgency surrounding

Indexed as

AlkaloidsAntifungal AgentsAntsBiofilmsCandida aurisMicrobial Sensitivity TestsAnimalsAnt VenomsCandidiasisFire AntsAlkaloidsAntifungal AgentsAnt VenomsalkaloidbiofilmCandida auriscandidiasissolenopsinsSolenopsis invicta

Identifiers

PMID39370781
PMCPMC11469440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.